BIOFABRICATING THE FUTURE
Engineering human tissue. Transforming medicine.
We bioprint nasal cartilage to accelerate drug development and advance regenerative solutions for facial reconstruction.
REGENERATIVE BIOENGINEERING PLATFORM
Building the future of regenerative nasal tissue platforms.
NovusTex is developing a reproducibility-driven bioengineering platform that enables intranasal therapeutic development today and supports future craniofacial reconstruction.
TODAY
Therapeutic development
- Intranasal toxicity testing
- Formulation optimization
- Drug absorption & diffusion studies
- Local tissue interaction analysis
- Translational preclinical screening
FOUNDATION
Bioengineering platform
- Biomaterial design & selection
- Cell-based tissue engineering
- Controlled tissue architecture
- Standardized fabrication workflows
- Iterative testing & optimization
THE PLATFORM
Building a scalable regenerative bioengineering platform.
01
PLATFORM FOCUS
Nasal tissue engineering
A defined entry point with scalable expansion potential.
02
CORE SYSTEM
Reproducibility-driven workflow
Curate → Standardize → Print → Test → Refine.
03
APPLICATION SCOPE
Therapeutic development + regenerative reconstruction
Near-term value with long-term potential.
04
COLLABORATION MODEL
Open to pharma, biotech & research partnerships
Enabling translational innovation.
LEADERSHIP
Leadership driving regenerative innovation.
Built by a team bridging medicine and engineering to translate complex biology into scalable, high-impact therapeutic platforms.
Dr. Sahil Khan
CO-FOUNDER & CEO
Leading NovusTex with a vision to transform how engineered tissues are designed and translated into real-world applications.
LinkedIn
Ryan Idnani
CO-FOUNDER & CTO
Builds the scientific foundation enabling NovusTex's platform for therapeutic development and regenerative applications.
LinkedIn
WHY IT MATTERS
From conventional models to engineered tissue systems.
Traditional in vitro models fail to capture the complexity and predictability of human nasal tissue.
NovusTex enables a transition to reproducible, high-fidelity engineered tissue systems designed for translational accuracy.